ASPIRE Intervention for High Blood Pressure
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to test a new approach called the ASPIRE Intervention for managing high blood pressure. It is designed to create training materials for patients and healthcare teams to ensure consistent care. Participants in the intervention group will receive standard care, a free blood pressure cuff, and the new ASPIRE components. In contrast, the control group will receive standard care and a blood pressure cuff. This trial suits adults who have had high blood pressure for at least a year, have had a recent clinic visit, and are taking medication to lower their blood pressure. As an unphased trial, this study offers participants the chance to contribute to innovative research that could enhance blood pressure management for many.
Do I have to stop taking my current medications for the trial?
The trial does not specify if you need to stop taking your current medications. However, since you must be on at least one blood pressure medication to participate, it seems likely you will continue your current treatment.
What prior data suggests that the ASPIRE Intervention is safe for high blood pressure patients?
Research has shown that the ASPIRE Intervention is likely safe for people. Participants in studies have generally tolerated it well. The intervention enables patients to monitor their blood pressure independently, with some assistance from healthcare providers. No major reports of serious side effects have emerged. This suggests that the ASPIRE Intervention is probably safe for those considering joining the trial.12345
Why are researchers excited about this trial?
Researchers are excited about the ASPIRE Intervention for high blood pressure because it combines usual care with innovative support components, aiming to enhance patient engagement and management of their condition. Unlike standard treatments that primarily rely on medications like ACE inhibitors or beta-blockers, ASPIRE includes a free blood pressure cuff and additional supportive elements tailored to improve adherence and lifestyle changes. This holistic approach could lead to better long-term outcomes by empowering patients to take an active role in managing their blood pressure.
What evidence suggests that the ASPIRE Intervention is effective for high blood pressure?
Research has shown that the ASPIRE Intervention, which participants in this trial may receive, can help lower blood pressure. One study found that people using this method experienced a drop of 18.5 points in their top blood pressure number after six months, while those not using it saw only a 6.6-point decrease. Another study reported a smaller decrease of 4.9 points for those using the intervention compared to those who didn't. These findings suggest that the ASPIRE Intervention could be highly effective in managing high blood pressure.12345
Who Is on the Research Team?
Rasha Khatib, PhD
Principal Investigator
Advocate Aurora Research Institute
Are You a Good Fit for This Trial?
The ASPIRE trial is for adults 18 years or older with a history of high blood pressure for at least one year. Participants must have had an elevated blood pressure reading during their qualifying visit and be on medication to lower blood pressure. They also need to be able to give consent.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants in the intervention arm receive a blood pressure monitoring device, training, and support on self-measured blood pressure, along with addressing social determinants of health.
Control
Participants in the control arm receive a blood pressure monitoring device and usual care.
Follow-up
Participants are monitored for safety and effectiveness after the intervention, including patient and care team acceptability and satisfaction.
What Are the Treatments Tested in This Trial?
Interventions
- ASPIRE Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Advocate Health Care
Lead Sponsor
Wake Forest University Health Sciences
Lead Sponsor